Arcus’s highest priority is to execute on its ongoing Phase 3 trial and overall development plan aimed at establishing casdatifan as the standard-of-care and backbone therapy for clear cell renal cell ...

By ending its agreement with ImmuneOnco, Instil is also handing back the other asset from the licensing deal: IMM27M, a next-gen anti-CTLA-4 antibody that ImmuneOnco had taken into phase 1 trials as a ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...

Proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.

“Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior ...

TCL, a global leader in consumer electronics and the world's No. 1 Mini LED and ultra-large TV brand, today unveils a new generation of visual technology breakthroughs and AI-powered products at CES ...

Partnership has already generated high-quality, AI-ready data in less than three months ...

Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how ...